Evidence map›Paper›PMID 37562753›Full record

ArticleThe Journal of allergy and clinical immunology2023

Complement C1q essential for aeroallergen sensitization via CSF1R

Hyung-Geun Moon, Jacob D Eccles, Seung-Jae Kim, Ki-Hyun Kim, Young-Mee Kim, Jalees Rehman, Hyun Lee, Pinal Kanabar, John W Christman, Steven J Ackerman and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Fungal immunization potentiates CD4Frontiers in immunology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Hyung-Geun MoonDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago. Electronic address: hmoon22@uic.edu.
Jacob D EcclesDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago.
Seung-Jae KimDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago.
Ki-Hyun KimDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago.
Young-Mee KimDepartment of Pharmacology, University of Illinois College of Medicine, Chicago.
Jalees RehmanDepartment of Pharmacology, University of Illinois College of Medicine, Chicago.
Hyun LeeCollege of Pharmacy, University of Illinois at Chicago, Chicago.
Pinal KanabarResearch Informatics Core, University of Illinois at Chicago, Chicago.
John W ChristmanSection of Pulmonary, Critical Care, and Sleep Medicine, Columbus; Davis Heart and Lung Research Center, The Ohio State University, Columbus.
Steven J AckermanDepartment of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago; Department of Medicine, University of Illinois at Chicago, Chicago.
Christian AscoliDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago.
Homan KangGordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston.
Hak Soo ChoiGordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston.
Minhyung KimDepartment of Surgery, Cedars-Sinai Medical Center, Los Angeles; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles.
Sungyong YouDepartment of Surgery, Cedars-Sinai Medical Center, Los Angeles; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles.
Gye Young ParkDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago; Jesse Brown Veterans Affairs Medical Center, Chicago. Electronic address: parkgy@uic.edu.
University of Illinois Chicago · USCedars-Sinai Medical Center · USHarvard University · USUniversity of Illinois Urbana-Champaign · USColumbus State University · US

Funding

Strengthening Stakeholder Engagement in Human Research Protections.UL1TR002003 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARNIK, NIRANJAN SUBHASH, MERMELSTEIN, ROBIN J. · 2016 to 2024
$33.7M
Synthetic Biology and Optogenetics CoreP01HL151327 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARGINOV, ANDREI V · 2021 to 2025
$11.8M
Institutional Career DevelopmentKL2TR002002 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PHILLIPS, SHANE A · 2016 to 2024
$6.8M
REGULATION OF THE MACROPHAGE INFLAMMATORY PHENOTYPE IN ARDSR01HL137224 · NHLBI · OHIO STATE UNIVERSITY · PI CHRISTMAN, JOHN W, KARPURAPU, MANJULA · 2018 to 2025
$4.5M
Mechanisms and Treatment of SARS-CoV-2 induced Lung Endothelial InjuryR01HL162308 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI REHMAN, JALEES, RICHNER, JUSTIN · 2022 to 2025
$2.9M
iPSC-Derived Vascularized Human Lung Organoids and Interaction Between Lung Endothelial Cells and Alveolar Epithelial CellsR01HL163978 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KADUR LAKSHMINARASIM, PREETISH, REHMAN, JALEES · 2022 to 2025
$2.9M
Mechanism of CX3CR1+ macrophage-mediated resolution of eosinophilic allergic lung inflammationR01HL153170 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PARK, GYE YOUNG · 2021 to 2025
$2.9M
Role of alternatively activated macrophages in allergic asthmaR01HL126852 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PARK, GYE YOUNG · 2016 to 2020
$2.0M
Heterogeneity and cellular hierarchy of lung cDC2R21AI171517 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PARK, GYE YOUNG · 2023 to 2024
$440k
CSF1 Receptor-Mediated Tumor Microenvironment in Lung CancerI01BX004981 · VA · JESSE BROWN VA MEDICAL CENTER · PI PARK, GYE YOUNG · 2020 to 2025
–
BLRD VA I01 BX004981NCATS NIH HHS KL2 TR002002NCATS NIH HHS UL1 TR002003NHLBI NIH HHS P01 HL151327NHLBI NIH HHS R01 HL126852NHLBI NIH HHS R01 HL137224NHLBI NIH HHS R01 HL153170NHLBI NIH HHS R01 HL162308NHLBI NIH HHS R01 HL163978NIAID NIH HHS R21 AI171517
6 · The paper itself

Abstract

backgroundDendritic cells (DCs) are heterogeneous, comprising multiple subsets with unique functional specifications. Our previous work has demonstrated that the specific conventional type 2 DC subset, CSF1R

objectiveIt remains to be understood how CSF1R

methodsWe applied single-cell RNA sequencing to mouse lung DCs. Conventional DC-selective knockout mouse models were employed, and mice were subjected to inhaled allergen sensitization with multiple readouts of asthma pathology. Under the clinical arm of this work, human lung transcriptomic data were integrated with mouse data, and bronchoalveolar lavage (BAL) specimens were collected from subjects undergoing allergen provocation, with samples assayed for C1q.

resultsWe found that C1q is selectively enriched in lung CSF1R

conclusionsC1q is secreted from the CSF1R

Indexed as

AsthmaPneumoniaAllergensAnimalsComplement C1qDendritic CellsHumansMiceMice, KnockoutReceptor Protein-Tyrosine KinasesReceptors, Colony-Stimulating FactorAllergensC1qa protein, mouseComplement C1qReceptor Protein-Tyrosine KinasesReceptors, Colony-Stimulating Factorallergen sensingallergic asthmaColony stimulating factor 1 receptor (CSF1R)complement component 1q (C1q)conventional dendritic cell type 2 (cDC2)

Identifiers

PMID37562753
PMCPMC10923196
OpenAlexW4385660977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.